The two-shot combo called Cabenuva is expected to make it easier for people to stay on track with their HIV medicines and to do so with more privacy.

U.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now used to control infection with the AIDS virus.

Under FDA emergency-use authorization, doctors successfully resolved COVID-19 in a seriously ill, immunodeficient woman using a very high-neutralizing antibody-titer convalescent plasma from a recovered COVID-19 patient. However, further study suggested that use of convalescent plasma may not be warranted in many cases, for two reasons: 1) titer levels are too low in many convalescent plasmas, and 2) there are high endogenous neutralizing antibody titers already present in COVID-19 patients prior to infusion.

Here's the latest for Friday, January 15th: Capitol rioters included highly trained ex-military, cops; Biden taps former FDA chief to lead vaccine rollout; Dozens dead in Indonesia earthquake; Polar bears enjoy snow at Yorkshire Wildlife Park

President-elect Joe Biden introduced a $1.9 trillion spending package. A study finds the pandemic has lowered Americans' life expectancy. Latest news.

The game, EndeavorRx, is designed to improve attention spans in patients ages 8 to 12.

The U.S. Food and Drug Administration has cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in...